Secondary AML/MDS
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients (NCT01319864) | Seattle Children's Hospital | 2011-03-01 |
Track Secondary AML/MDS automatically
Every clearance here is in the API, with alerts when new ones post.